Hazte socio de la SAMFyC

Última publicación SAMFyC: Actualización en MF y APS

 

AULA VIRTUAL SAMFyC

Aula de formación virtual de SAMFyC

SAMFyC CONGRESOS

Historico de Comunicaciones
presentadas a los Congresos
Andaluces de MFyC (SAMFyC), desde 2008.


* * * * * * * * * * * * * * * * * * * * * * * * *

Información Socios

Ofertas de Trabajo
Ofertas de Trabajo SOCIOS SAMFYC

¡Actualiza tus datos!
Actualiza tus datos

 

Buscador de Contenidos

Sociedades Federadas

Medicina Familiar y Comunitaria

Sociedades Científicas de Medicina Familiar y Comunitaria

Enlaces de Interés

Consulte Nuestros Enlaces.
Enlaces de Interés

Acceso Socios



Buscador de publicaciones externas y alertas bibliográficas

Junio 2012 PDF Imprimir E-mail
Escrito por Administrador General de SAMFyC   
Jueves, 05 de Julio de 2012 00:00

SELECCIÓN DE REFERENCIAS BIBLIOGRÁFICAS DE LO PUBLICADO EN RELACIÓN CON ATENCIÓN PRIMARIA

Selección realizada por Antonio Manteca González

ACADEMIC MEDICINE

Kirch DG, Nivet MA, Berlin A. Commentary: who will help the United States attain the goal of health equity? Acad Med. 2012; 87: 689-690 [AO,I]

22643375             R/C

COMENTARIO: ¿QUIÉN AYUDARÁ A LOS ESTADOS UNIDOS A CONSEGUIR EL OBJETIVO DE LA EQUIDAD SANITARIA?

 

Peek ME, Wilson SC, Bussey-Jones J, Lypson M, Cordasco K, Jacobs EA, ET AL. A study of national physician organizations' efforts to reduce racial and ethnic health disparities in the United States. Acad Med. 2012; 87: 694-700 [T,I]

22534593             R/C

ESTUDIO DE LOS ESFUERZOS DE LAS ORGANIZACIONES NACIONALES DE MÉDICOS PARA REDUCIR LAS DISPARIDADES SANITARIAS RACIALES Y ÉTNICAS EN LOS ESTADOS UNIDOS

 

Kusurkar RA, Croiset G, Mann KV, Custers E, Ten Cate O. Have motivation theories guided the development and reform of medical education curricula? a review of the literature. Acad Med. 2012; 87: 735-743 [R,I]

22534597             R/C

¿HAN GUIADO LAS TEORÍAS DE LA MOTIVACIÓN EL DESARROLLO Y LA REFORMA DE LOS CURRÍCULOS FORMATIVOS MÉDICOS? REVISIÓN DE LA LITERATURA

 

ANNALS OF INTERNAL MEDICINE

Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012; 156: 785-795 [M,I]

22312131             R/C

ECUACIONES ESTIMATIVAS DELA TASA DE FILTRACIÓN GLOMERULAR EN LA ERA DE LA ESTANDARIZACIÓN DE LA CREATININA: REVISIÓN SISTEMÁTICA

 

Nelson HD, Bougatsos C, Blazina I. Screening women for intimate partner violence: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2012; 156: 796-808 [M,II]

22565034             R/C

CRIBAR A LAS MUJERES RESPECTO A LA VIOLENCIA DEL COMPAÑERO ÍNTIMO: REVISIÓN SISTEMÁTICA PARA LA ACTUALIZACIÓN DE LA RECOMENDACIÓN DEL US PREVENTIVE SERVICES TASK FORCE

 

Roumie CL. The doughnut hole: it's about medication adherence. Ann Intern Med. 2012; 156: 834-835 [AO,I]

22665817

EL AGUJERO DEL DONUT: ES EL CUMPLIMIENTO DE LA MEDICACIÓN

 

Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a danish nationwide cohort study. Ann Intern Med. 2012; 156: 841-847 [S,I]

22711076             R/C

RIESGO DE CARCINOMA HEPATOCELULAR EN PACIENTES CON CIRROSIS ALCOHÓLICA: ESTUDIO DE COHORTES NACIONAL DANÉS

 

Fong TG, Jones RN, Marcantonio ER, Tommet D, Gross AL, Habtemariam D, et al. Adverse outcomes after hospitalization and delirium in persons with Alzheimer disease. Ann Intern Med. 2012; 156: 848-856 [S,I]

22711077             R/C

RESULTADOS ADVERSOS TRAS HOSPITALIZACIÓN Y SÍNDROME CONFUSIONAL EN PERSONAS CON ENFERMEDAD DE ALZHEIMER

 

Shamliyan T, Wyman JF, Ramakrishnan R, Sainfort F, Kane RL. Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Ann Intern Med. 2012; 156: 861-874 [M,I]

22711079             R/C

BENEFICIOS Y PERJUICIOS DEL TRATAMIENTO FARMACOLÓGICO DE LA INCONTINENCIA URINARIA EN MUJERES: REVISIÓN SISTEMÁTICA

 

Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 156: 880-891 [M,II]

22711081             R/C

CRIBAJE DEL CÁNCER DE CÉRVIX: DECLARACIÓN DE RECOMENDACIÓN DEL US PREVENTIVE SERVICES TASK FORCE

 

Reichenbach S, Jüni P. Medical food and food supplements: not always as safe as generally assumed. Ann Intern Med. 2012; 156: 894-895 [AO,I]

22711083

ALIMENTOS MÉDICOS Y SUPLEMENTOS ALIMENTARIOS: NO SIEMPRE TAN SEGUROS COMO GENERALMENTE  SE PRESUPONE

 

Kizer N, Peipert JF. Cervical cancer screening: primum non nocere. Ann Intern Med. 2012; 156: 896-897 [AO,I]

22711084

CRIBAJE DEL CÁNCER DE CÉRVIX: PRIMUM NON NOCERE

 

ARCHIVES OF GENERAL PSYCHIATRY

Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 [Epub ahead of print] [M,I]

22393205             R/C

BENEFICIOS DE LOS ANTIDEPRESIVOS: SÍNTESIS DE LOS RESULTADOS EN EL PACIENTE A LAS 6 SEMANAS DE ENSAYOS ALEATORIZADOS A DOBLE CIEGO CONTROLADOS CON PLACEBO CON FLUOXETINA Y VENLAFAXINA

 

Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, et al. Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study. Arch Gen Psychiatry. 2012 [Epub ahead of print] [S,I]

22309970             R/C

IMPACTO DEL TABACO SOBRE EL DECLIVE COGNITIVO EN LA VEJEZ TEMPRANA: ESTUDIO DE COHORTES WHITEHALL II

 

ARCHIVES OF INTERNAL MEDICINE

Leach R. The dilemma of prostate-specific antigen testing. Arch Intern Med. 2012; 172: 835-836 [AO,I]

EL DILEMA DE LA PRUEBA DEL PSA

 

Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012; 172: 837-844 [M,II]

22688992             R/C

TABAQUISMO Y MORTALIDAD POR CUALQUIER CAUSA EN PERSONAS ANCIANAS: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Lam TH. Absolute risk of tobacco deaths: one in two smokers will be killed by smoking: comment on "smoking and all-cause mortality in older people". Arch Intern Med. 2012; 172: 845-846 [AO,I]

22688993

RIESGO ABSOLUTO DE MUERTES POR TABACO: UNO DE CADA DOS FUMADORES MORIRÁ POR FUMAR: COMENTARIO SOBRE " TABAQUISMO Y MORTALIDAD POR CUALQUIER CAUSA EN PERSONAS ANCIANAS"

 

Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med. 2012; 172: 909-919 [M,II]

22732744             R/C

TERAPIA CON ESTATINAS EN LA PREVENCIÓN DE LOS ACONTECIMIENTOS CARDIOVASCULARES RECURRENTES: METAANÁLISIS BASADO EN EL SEXO

 

Taylor F, Ebrahim S. Statins work just as well in women as in men: comment on "statin therapy in the prevention of recurrent cardiovascular events". Arch Intern Med. 2012; 172: 919-920 [AO,I]

22732745

LAS ESTATINAS FUNCIONAN IGUAL DE BIEN EN MUJERES QUE EN HOMBRES: COMENTARIO SOBRE "TERAPIA CON ESTATINAS EN LA PREVENCIÓN DE LOS ACONTECIMIENTOS CARDIOVASCULARES RECURRENTES"

 

Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med. 2012; 172: 930-936 [CC,II]

22732749             R/C

AUMENTO DE LA APARICIÓN DE FRACTURAS FEMORALES ATÍPICAS ASOCIADAS AL USO DE BIFOSFONATOS

 

ARCHIVOS DE BRONCONEUMOLOGIA

Pacheco A, Faro V, Cobeta I, Royuela A. Tos crónica de escasa respuesta al tratamiento e incidencia de reflujo gastroesofágico . Arch Bronconeumol. 2012; 48: 197-201 [S,I]

22421522             R/C

TOS CRÓNICA DE ESCASA RESPUESTA AL TRATAMIENTO E INCIDENCIA DE REFLUJO GASTROESOFÁGICO

 

Izquierdo JL, Rodríguez JM. Utilización excesiva de corticoides inhalados en la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2012; 48: 207-212 [R,I]

22385832             R/C

UTILIZACIÓN EXCESIVA DE CORTICOIDES INHALADOS EN LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA

 

ARTHRITIS AND RHEUMATISM

Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012; 64: 1697-1707 [R,I]

22392533

ARTROSIS: ENFERMEDAD DE LA ARTICULACIÓN COMO ÓRGANO

 

ATENCION PRIMARIA

Marzo-Castillejo M, Mascort J, Rodríguez-Moñino AP. ¿Estamos convencidos de nuestro papel en la prevención y detección precoz del cáncer colorrectal? Aten Primaria. 2012; 44: 303-305 [AO,I]

22698064

¿ESTAMOS CONVENCIDOS DE NUESTRO PAPEL EN LA PREVENCIÓN Y DETECCIÓN PRECOZ DEL CÁNCER COLORRECTAL?

 

Laporte JR, Bosch M. Crisis y política de medicamentos. Aten Primaria. 2012; 44: 306-308 [AO,II]

22578399

CRISIS Y POLÍTICA DE MEDICAMENTOS

 

Martín I, Quintana S, Urzay V, Ganzarain E, Aguirre T, Pedrero JE. Fiabilidad del cuestionario VIDA, para valoración de Actividades Instrumentales de la Vida Diaria (AIVD) en personas mayores. Aten Primaria. 2012; 44: 309-317 [T,I]

21871691             R/C

FIABILIDAD DEL CUESTIONARIO VIDA, PARA VALORACIÓN DE ACTIVIDADES INSTRUMENTALES DE LA VIDA DIARIA (AIVD) EN PERSONAS MAYORES

 

Coll-De-Tuero G, Garre-Olmo J, López-Pousa S. Hacia una evaluación de las capacidades instrumentales de los ancianos validada en nuestro entorno. Aten Primaria. 2012; 44: 317-319 [AO,I]

22595473

HACIA UNA EVALUACIÓN DE LAS CAPACIDADES INSTRUMENTALES DE LOS ANCIANOS VALIDADA EN NUESTRO ENTORNO

 

Clotet J, Real J, Lorente I, Fuentes A, Paredes E, Ciria C. Espirometría como método de cribado y de intervención antitabaco en fumadores de alto riesgo en atención primaria. Aten Primaria. 2012; 44: 328-334 [T,I]

22088774             R/C

ESPIROMETRÍA COMO MÉTODO DE CRIBADO Y DE INTERVENCIÓN ANTITABACO EN FUMADORES DE ALTO RIESGO EN ATENCIÓN PRIMARIA

 

Simó J. Utilización de medicamentos en España y en Europa. Aten Primaria. 2012; 44: 335-347 [R,II]

22018798

UTILIZACIÓN DE MEDICAMENTOS EN ESPAÑA Y EN EUROPA

 

Moore P, Gómez G, Kurtz S. Comunicación médico-paciente: una de las competencias básicas pero diferente. Aten Primaria. 2012; 44: 358-365 [R,II]

22079197

COMUNICACIÓN MÉDICO-PACIENTE: UNA DE LAS COMPETENCIAS BÁSICAS PERO DIFERENTE

 

Marzo-Castillejo M, Melús E, Bellas B; Grupo de expertos de cáncer del PAPPS de semFYC. Recomendaciones para el cribado del cáncer de mama con mamografía en población de riesgo medio. Actualización PAPPS 2012. Aten Primaria. 2012; 44: 366-367 [M,II]

22608367             R/C

RECOMENDACIONES PARA EL CRIBADO DEL CÁNCER DE MAMA CON MAMOGRAFÍA EN POBLACIÓN DE RIESGO MEDIO

 

BRITISH JOURNAL OF PSYCHIATRY

Morriss R. Role of mental health professionals in the management of functional somatic symptoms in primary care. Br J Psychiatry. 2012; 200: 444-445 [AO,I]

22661676             R/C

PAPEL DE LOS PROFESIONALES DE SALUD MENTAL EN EL MANEJO DE LOS SÍNTOMAS SOMÁTICOS FUNCIONALES EN ATENCIÓN PRIMARIA

 

Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, et al. Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry. 2012; 200: 476-484 [T,I]

22322459             R/C

TRASTORMOS POR USO DE ALCOHOL Y CURSO DE LOS TRASTORNOS DE ANSIEDAD Y DEPRESIÓN

 

Schröder A, Rehfeld E, Ornbøl E, Sharpe M, Licht RW, Fink P. Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry. 2012; 200: 499-507 [EC,II]

22539780             R/C

TERAPIA COGNITIVO-CONDUCTUAL EN GRUPOS PARA UNA GAMA DE SÍNDROMES SOMÁTICOS FUNCIONALES: ENSAYO ALEATORIZADO

 

BRITISH MEDICAL JOURNAL

Yardley L, Barker F, Muller I, Turner D, Kirby S, Mullee M, et al. Clinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: single blind, parallel group, pragmatic, randomised controlled trial. BMJ. 2012; 344: e2237 [EC,I]

22674920             R/C

EFECTIVIDAD CLÍNICA Y ECONÓMICA DE LA REHABILITACIÓN VESTIBULAR  MEDIANTE FOLLETO PARA EL VÉRTIGO CRÓNICO EN ATENCIÓN PRIMARIA: ENSAYO ALEATORIZADO CONTROLADO, PRAGMÁTICO, CON GRUPO PARALELO Y ENMASCARAMIENTO SIMPLE

 

Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ. 2012; 344: e2333 [EC,I]

22539172             R/C

EFECTIVIDAD DE UN PROGRAMA DE AUTOMANEJO Y EDUCACIÓN EN DIABETES (DESMOND) PARA PERSONAS CON DIABETES MELLITUS TIPO 2 RECIÉN DIAGNOSTICADA: TRES AÑOS DE SEGUIMIENTO DE UN ENSAYO CONTROLADO ALEATORIZADO AGRUPADO EN ATENCIÓN PRIMARIA

 

Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Haase AM, Taylor AH, et al. Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ. 2012; 344: e2758 [EC,II]

22674921             R/C

ACTIVIDAD FÍSICA FACILITADA COMO TRATAMIENTO PARA ADULTOS CON DEPRESIÓN: ENSAYO CONTROLADO ALEATORIZADO

 

Schouten HJ, Koek HL, Oudega R, Geersing GJ, Janssen KJ, van Delden JJ, et al. Validation of two  age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis. BMJ. 2012; 344:e2985 [T,II]

22674922             R/C

VALIDACIÓN DE DOS VALORES DE CORTE DEL DÍMERO D DEPENDIENTES DE LA EDAD PARA LA EXCLUSIÓN DE TROMBOSIS VENOSA PROFUNDA EN PACIENTES MAYORES CON SOSPECHA DE ELLA: ANÁLISIS DIAGNÓSTICO TRANSVERSAL RETROSPECTIVO

 

Daley A, Jolly K. Exercise to treat depression. BMJ. 2012; 344: e3181 [R,I]

22674923

EJERCICIO PARA TRATAR LA DEPRESIÓN

 

Gill PJ, Harnden A, Karpe F. Familial hypercholesterolaemia. BMJ. 2012; 344: e3228 [R,I]

22581572

HIPERCOLESTEROLEMIA FAMILIAR

 

McMillan AM, Landorf KB, Gilheany MF, Bird AR, Morrow AD, Menz HB. Ultrasound guided corticosteroid  injection for plantar fasciitis: randomised controlled trial. BMJ. 2012; 344: e3260 [EC,I]

22619193             R/C

INYECCIÓN DE CORTICOIDES GUIADA POR ULTRASONIDOS PARA LA FASCITIS PLANTAR: ENSAYO CONTROLADO ALEATORIZADO

 

Treadwell JR. Pre-diabetes as a contributor to stroke. BMJ. 2012; 344: e3285 [AO,I]

22677794

PREDIABETES COMO CONTRIBUYENTE AL ICTUS

 

Lepper PM, Ott S, Nüesch E, von Eynatten M, Schumann C, Pletz MW, et al; on behalf of the German Community Acquired Pneumonia Competence Network (CAPNETZ). Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ. 2012; 344: e3397 [S,I]

22645184             R/C

NIVELES DE GLUCOSA PLASMÁTICA PARA PREDECIR LA MUERTE EN PACIENTES INGRESADOS EN EL HOSPITAL POR NEUMONÍA ADQUIRIDA EN LA COMUNIDAD: ESTUDIO DE COHORTES PROSPECTIVO

 

White PD, Rickards H, Zeman AZ. Time to end the distinction between mental and neurological illnesses. BMJ. 2012; 344: e3454 [R,I]

22628005

HORA DE ACABAR CON LA DISTINCIÓN ENTRE ENFERMEDADES MENTALES Y NEUROLÓGICAS

 

Seshadri S, Oakeshott P, Nelson-Piercy C, Chappell LC. Prepregnancy care. BMJ. 2012; 344: e3467 [R,I]

22654073

ATENCIÓN PREGESTACIONAL

 

Genders TS, Steyerberg EW, Hunink MG, Nieman K, Galema TW, Mollet NR, et al. Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ. 2012; 344: e3485 [M,II]

22692650             R/C

MODELO PREDICTIVO PARA ESTIMAR LA PRESENCIA DE ENFERMEDAD ARTERIAL CORONARIA: ANÁLISIS COMBINADO RETROSPECTIVO DE COHORTES EXISTENTES

 

Hillaire-Buys D, Faillie JL. Pioglitazone and the risk of bladder cancer. BMJ. 2012; 344: e3500 [AO,I]

22653979

PIOGLITAZONA Y RIESGO DE CÁNCER DE VEJIGA

 

Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012; 344: e3502 [R,II]

22645185

PREVENIR EL SOBREDIAGNÓSTICO: CÓMO DEJAR DE DAÑAR A LOS SANOS

 

Lee M, Saver JL, Hong KS, Song S, Chang KH, Ovbiagele B. Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ. 2012; 344: e3564 [M,II]

22677795             R/C

EFECTO DE LA PREDIABETES SOBRE EL RIESGO FUTURO DE ICTUS: METAANÁLISIS

 

Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, Pollak MN, et al. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ. 2012; 344: e3645 [CC,II]

22653981             R/C

USO DE LA PIOGLITAZONAY RIESGO DE CÁNCER DE VEJIGA EN PERSONAS CON DIABETES TIPO 2: ESTUDIO DE CASO-CONTROL ANIDADO

 

Zomer E, Owen A, Magliano DJ, Liew D, Reid CM. The effectiveness and cost effectiveness of dark  chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best  case scenario analysis using a Markov model. BMJ. 2012; 344: e3657 [T,I]

22653982             R/C

EFECTIVIDAD Y RENTABILIDAD DEL CONSUMO DE CHOCOLATE NEGRO COMO TERAPIA DE PREVENCIÓN EN PERSONAS CON ALTO RIESGO DE ENFERMEDAD CARDIOVASCULAR: ANÁLISIS DE PANORAMA DE MEJOR CASO USANDO UN MODELO DE MARKOV

 

Godlee F. Preventing overdiagnosis. BMJ. 2012; 344: e3783 [AO,I]

PREVENIR EL SOBREDIAGNÓSTICO

 

Prescott E, Sørensen R. Female sex as a risk factor for stroke in atrial fibrillation. BMJ. 2012; 344: e3789 [R,I]

22653983

SEXO FEMENINO COMO FACTOR DE RIESGO DE ICTUS EN LA FIBRILACIÓN AURICULAR

 

Smeeth L, Hemingway H. Improving vascular health: are pills the answer? BMJ. 2012; 344: e3802 [AO,I]

22654067

MEJORAR LA SALUD VASCULAR: ¿SON LAS PÍLDORAS LA RESPUESTA?

 

Haut ER, Lau BD, Streiff MB. New oral anticoagulants for preventing venous thromboembolism. BMJ. 2012; 344: e3820 [R,II]

22700786

NUEVOS ANTICOAGULANTES ORALES PARA PREVENIR EL TROMBOEMBOLISMO VENOSO

 

Brewer C. Psychoanalysis can seriously damage your health. BMJ. 2012; 344: e3857 [AO,I]

22654070

EL PSICOANÁLISIS PUEDE DAÑAR GRAVEMENTE SU SALUD

 

Spence D. Bad medicine: dementia. BMJ. 2012; 344: e3859 [AO,I]

22661738

MALA MEDICINA: DEMENCIA

 

Godlee F. Integrated care is what we all want. BMJ. 2012; 344: e3959 [AO,I]

ATENCIÓN INTEGRAL ES LO QUE TODOS QUEREMOS

 

Ahmed H, Naik G, Willoughby H, Edwards AG. Communicating risk. BMJ. 2012; 344: e3996 [R,I]

22709962

RIESGO DE COMUNICACIÓN

 

Hughes J. The primary-secondary care divide fails older patients. BMJ. 2012; 344: e4009 [AO,I]

22700789

LA DIVISIÓN ATENCIÓN PRIMARIA-SECUNDARIA FRACASA EN LOS PACIENTES MÁS MAYORES

 

Spence D. Why doctors should support welfare reform. BMJ. 2012; 344: e4054 [AO,I]

22695908

POR QUÉ LOS MÉDICOS DEBERÍAMOS APOYAR LA REFORMA DEL ESTADO DEL BIENESTAR

 

Godlee F. Assisted dying. BMJ. 2012; 344: e4075 [AO,I]

22695306

MUERTE AYUDADA

 

Godlee F. More marketing than science. BMJ. 2012; 344: e4269 [AO,I]

MÁS MARKETING QUE CIENCIA

 

CANADIAN MEDICAL ASSOCIATION JOURNAL

Kirmayer LJ. Changing patterns in suicide among young people. CMAJ. 2012; 184: 1015-1016 [AO,I]

22470168

PAUTAS CAMBIANTES EN EL SUICIDIO ENTRE LAS PERSONAS JÓVENES

 

Plourde G, Prud'homme D. Managing obesity in adults in primary care. CMAJ. 2012; 184: 1039-1044 [R,I]

22586330

MANEJAR LA OBESIDAD EN LOS ADULTOS EN ATENCIÓN PRIMARIA

 

CIRCULATION

Thanassoulis G, Lyass A, Benjamin EJ, Larson MG, Vita JA, Levy D, et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart study. Circulation. 2012; 125: 2836-2843 [S,II]

22572915             R/C

RELACIONES DE LA RESPUESTA DE LA PRESIÓN ARTERIAL AL EJERCICIO CON LOS FACTORES DE RIESGO CARDIOVASCULAR Y LA FUNCIÓN VASCULAR EN EL  FRAMINGHAM HEART STUDY

 

Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012; 125: 2933-2943 [R,II]

22689930

SÍNTOMAS Y ESTADO FUNCIONAL DE LOS PACIENTES CON FIBRILACIÓN AURICULAR: SITUACIÓN ACTUAL Y OPORTUNIDADES FUTURAS DE INVESTIGACIÓN

 

Rodriguez CJ. Disparities in ideal cardiovascular health: a challenge or an opportunity? Circulation. 2012; 125: 2963-2964 [AO,I]

22619285

DISPARIDADES EN LA SALUD CARDIOVASCULAR IDEAL: ¿RETO U OPORTUNIDAD?

 

Van Veldhuisen DJ, Maass AH. Telemonitoring of outpatients with heart failure: a search for the holy grail? Circulation. 2012; 125: 2965-2967 [AO,I]

22626742

TELEMONITORIZACIÓN DE PACIENTES AMBULATORIOS CON INSUFICIENCIA CARDIACA: ¿BÚSQUEDA DEL SANTO GRIAL?

 

Idris AH, Guffey D, Aufderheide TP, Brown S, Morrison LJ, Nichols P, et al; the Resuscitation Outcomes Consortium (ROC) Investigators. Relationship between chest compression rates and outcomes from cardiac arrest. Circulation. 2012; 125: 3004-3012 [T,I]

22623717             R/C

RELACIÓN ENTRE LAS TASAS DE COMPRESIÓN TORÁCICA Y LOS RESULTADOS EN LA PARADA CARDIACA

 

DIABETES CARE

Friedman EA. Optimizing care in diabetes: a quixotic challenge. Diabetes Care. 2012; 35: 1204-1205 [AO,I]

22619287

OPTIMIZAR LA ATENCIÓN A LA DIABETES: UN RETO QUIJOTESCO

 

Fonseca VA, Alvarado-Ruiz R, Raccah D, Boka G, Miossec P, Gerich JE; on behalf of the EFC6018 GetGoal-Mono Study Investigators. Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono). Diabetes Care. 2012; 35: 1225-1231 [EC,I]

22432104             R/C

EFICACIA Y SEGURIDAD DEL AGONISTA DEL RECEPTOR GLP-1 LIXISENATIDA UNA VEZ AL DÍA EN MONOTERAPIA: ENSAYO ALEATORIZADO, A DOBLE CIEGO, CONTROLADO CON PLACEBO EN PACIENTES CON DIAB ETES TIPO 2 (GETGOAL-MONO)

 

Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012; 35: 1239-1245 [C,I]

22538012             R/C

APOYO FAMILIAR, CUMPLIMIENTO DE LA MEDICACIÓN Y CONTROL GLUCÉMICO ENTRE ADULTOS CON DIABETES TIPO 2

 

Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012; 35: 1252-1257 [S,I]

22619288             R/C

TENDENCIAS EN LAS TASAS DE MORTALIDAD ENTRE ADULTOS EN EE UU CON Y SIN DIABETES ENTRE 1997 Y 2006: HALLAZGOS DE LA ENCUESTA NACIONAL DE ENTREVISTA DE SALUD

 

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012; 35: 1279-1284 [T,I]

22511257             R/C

IMPACTO DEL INCUMPLIMIENTO DEL TRATAMIENTO SOBRE LA MORTALIDAD EN PERSONAS CON DIABETES TIPO 2

 

McEwen LN, Karter AJ, Waitzfelder BE, Crosson JC, Marrero DG, Mangione CM, et al. Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2012; 35: 1301-1309 [S,II]

22432119             R/C

PREDICTORES DE MORTALIDAD A OCHO AÑOS EN PPACIENTES DIABÉTICOS TIPO 2: TRANSLATING RESEARCH INTO ACTION FOR DIABETES (TRIAD)  (Traducir la investigación en acción en la diabetes)

 

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35: 1364-1379 [M,II]

22517736

MANEJO DE LA HIPERGLUCEMIA EN LA DIABETES TIPO 2: ABORDAJE CENTRADO EN EL PACIENTE: DECLARACIÓN DE LA POSICIÓN DE LA ADA Y LA EASD

 

DRUGS

Frampton JE. Mometasone/Formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids. Drugs. 2012; 72: 1229-1241 [R,I]

22568730             R/C

AEROSOL INHALADO DE MOMETASONA/FORMOTEROL: EN EL ASMA NO CONTROLADA CON CORTICOIDES INHALADOS A DOSIS MEDIAS Y ALTAS

 

Carter NJ. Bilastine: in allergic rhinitis and urticaria. Drugs. 2012; 72: 1257-1269 [R,I]

22686617             R/C

BILASTINA: EN LA RINITIS ALÉRGICA Y LA URTICARIA

 

EUROPEAN HEART JOURNAL

Piccini JP, Singer DE. Putting risk prediction in atrial fibrillation into perspective. Eur Heart J. 2012; 33: 1431-1433 [AO,I]

22378796

PONER EN PERSPECTIVA LA PREDICCIÓN DEL RIESGO EN LA FIBRILACIÓN AURICULAR

 

Visser ME, Witztum JL, Stroes ES, Kastelein JJ. Antisense oligonucleotides for the treatment of dyslipidaemia. Eur Heart J. 2012; 33: 1451-1458 [R,II]

22634577             R/C

OLIGONUCLEÓTIDOS ANTISENTIDO EN EL TRATAMIENTO DE LA DISLIPEMIA

 

Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012; 33: 1500-1510 [S,II]

22246443             R/C

ESQUEMAS DE EVALUACIÓN DE LA ESTRATIFICACIÓN DEL RIESGO DE ICTUS ISQUÉMICO Y DE SANGRADO EN 182.678 PACIENTES CON FIBRILACIÓN AURICULAR: ESTUDIO DE COHORTES SWEDISH ATRIAL FIBRILLATION

 

FAMILY MEDICINE

Faricy L, Page T, Ronick M, Rdesinski R, Devoe J. Patterns of empiric treatment of Chlamydia trachomatis infections in an underserved population. Fam Med. 2012; 44: 408-415 [T,I]

22733418             R/C

PAUTAS DE TRATAMIENTO EMPÍRICO DE LAS INFECCIONES POR CHLAMYDIA TRACHOMATIS EN UNA POBLACIÓN CON ESCASA ATENCIÓN MÉDICA

 

Smith KJ, Clark S, Kapoor WN, Handler SM. Information primary care physicians want to receive about their hospitalized patients. Fam Med. 2012; 44: 425-430 [T,II]

22733420             R/C

LA INFORMACIÓN QUE LOS MÉDICOS DE ATENCIÓN PRIMARIA QUIEREN RECIBIR SOBRE SUS PACIENTES HOSPITALIZADOS

 

Goldberg A, Rickler KS, Sullivan G, Nothnagle M. Putting residents in the driver's seat: a new approach to teaching group medical visits. Fam Med. 2012; 44: 431-435 [C,I]

22733421             R/C

PONER A LOS RESIDENTES EN EL ASIENTO DEL CONDUCTOR: NUEVO ABORDAJE PARA ENSEÑAR VISITAS MÉDICAS EN GRUPO

 

FAMILY PRACTICE

Dawes M. Symptoms, reasons for encounter and diagnoses. Family practice is an international discipline. Fam Pract. 2012; 29: 243-244 [AO,II]

22421059

SÍNTOMAS, RAZONES PARA LA CONSULTA Y DIAGNÓSTICOS

 

Schumann I, Schneider A, Kantert C, Löwe B, Linde K. Physicians' attitudes, diagnostic process and barriers regarding depression diagnosis in primary care: a systematic review of qualitative studies. Fam Pract. 2012; 29: 255-263 [M,II]

22016322             R/C

ACTITUDES DEL MÉDICO, PROCESO DIAGNÓSTICO Y BARRERAS RESPECTO AL DIAGNÓSTICO DE  DEPRESIÓN EN ATENCIÓN PRIMARIA: REVISIÓN SISTEMÁTICA DE ESTUDIOS CUALITATIVOS

 

Uijen AA, Schers HJ, Schellevis FG, van den Bosch WJ. How unique is continuity of care? A review of continuity and related concepts. Fam Pract. 2012; 29: 264-271 [R,I]

22045931             R/C

¿CÓMO DE EXCLUSIVO ES EL CONCEPTO DE CONTINUIDAD DE LA ATENCIÓN? REVISIÓN DE LA CONTINUIDAD Y CONCEPTOS RELACIONADOS

 

Soler JK, Okkes I. Reasons for encounter and symptom diagnoses: a superior description of patients' problems in contrast to medically unexplained symptoms (MUS). Fam Pract. 2012; 29: 272-282 [R,II]

22308181             R/C

RAZONES PARA LA CONSULTA Y DIAGNÓSTICO DE LOS SÍNTOMAS: DESCRIPCIÓN SUPERIOR DE LOS PROBLEMAS DE LOS PACIENTES EN CONTRASTE CON LOS SÍNTOMAS SIN EXPLICACIÓN MÉDICA

 

Soler JK, Okkes I, Oskam S, van Boven K, Zivotic P, Jevtic M, et al; for the Transition Project. An international comparative family medicine study of the Transition Project data from the Netherlands, Malta and Serbia. Is family medicine an international discipline? Comparing incidence and prevalence rates of reasons for encounter and diagnostic titles of episodes of care across populations. Fam Pract. 2012; 29: 283-298 [T,II]

22308182             R/C

ESTUDIO DE MEDICINA DE FAMILIA INTERNACIONAL COMPARADA A PARTIR DE LOS DATOS DEL TRANSITION PROJECT DE HOLANDA, MALTA Y SERBIA ¿ES UNA DISCIPLINA INTERNACIONAL LA MEDICINA DE FAMILIA? COMPARACIÓN DE LAS TASAS DE INCIDENCIA Y PREVALENCIA DE LAS RAZONES PARA CONSULTAR Y LOS TÍTULOS DIAGNÓSTICOS DE LOS EPISODIOS DE ATENCIÓN A TRAVÉS DE LAS POBLACIONES

 

Soler JK, Okkes I, Oskam S, van Boven K, Zivotic P, Jevtic M, et al; for the Transition Project. An international comparative family medicine study of the Transition Project data from the Netherlands, Malta and Serbia. Is family medicine an international discipline? Comparing diagnostic odds ratios across populations. Fam Pract. 2012; 29: 299-314 [T,II]

22308178             R/C

ESTUDIO DE MEDICINA DE FAMILIA INTERNACIONAL COMPARADA A PARTIR DE LOS DATOS DEL TRANSITION PROJECT DE HOLANDA, MALTA Y SERBIA ¿ES UNA DISCIPLINA INTERNACIONAL LA MEDICINA DE FAMILIA? COMPARACIÓN DE LOS ODDS TARIOS DE DIAGNÓSTICO A TRAVÉS DE LAS POBLACIONES

 

Soler JK, Okkes I, Oskam S, van Boven K, Zivotic P, Jevtic M, et al; for the Transition Project. An international comparative family medicine study of the Transition Project data from the Netherlands, Malta, Japan and Serbia. An analysis of diagnostic odds ratios aggregated across age bands, years of observation and individual practices. Fam Pract. 2012; 29: 315-331 [T,II]

22308180             R/C

ESTUDIO DE MEDICINA DE FAMILIA INTERNACIONAL COMPARADA A PARTIR DE LOS DATOS DEL TRANSITION PROJECT DE HOLANDA, MALTA, JAPÓN Y SERBIA. ANÁLISIS DE LAS ODDS RATIOS DE DIAGNÓSTICO A TRAVÉS DE LAS FRANJAS DE EDAD, AÑOS DE OBSERVACIÓN Y PRÁCTICAS INDIVIDUALES

 

Nexøe J, Damsbo B, Lund JO, Munck A. Measurement of blood pressure, ankle blood pressure and calculation of ankle brachial index in general practice. Fam Pract. 2012; 29: 345-351 [T,I]

22024665             R/C

MEDIDA DE LA PRESIÓN ARTERIAL, LA PRESIÓN ARTERIAL DEL TOBILLO Y CÁLCULO DEL ÍNDICE TOBILLO-BRAZO EN LA CONSULTA GENERAL

 

Vazquez-Lago JM, Lopez-Vazquez P, López-Durán A, Taracido-Trunk M, Figueiras A. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. Fam Pract. 2012; 29: 352-360 [C,I]

22016323             R/C

ACTITUDES DE LOS MÉDICOS DE ATENCIÓN PRIMARIA PARA PRESCRIBIR ANTIBIÓTICOS Y RESISTENCIA MICROBIANA: ESTUDIO CUALITATIVO EN ESPAÑA

 

Hanna L, May C, Fairhurst K. The place of information and communication technology-mediated consultations in primary care: GPs' perspectives. Fam Pract. 2012; 29: 361-366 [C,I]

22006040             R/C

EL LUGAR DE LAS CONSULTAS A TRAVÉS DE TECNOLOGÍAS DE LA INFORMACIÓN Y LA COMUNICACIÓN EN ATENCIÓN PRIMARIA: PERSPECTIVAS DE LOS MÉDICOS GENERALES

 

GACETA SANITARIA

Gabarrón E, Fernández-Luque L. eSalud y vídeos online para la promoción de la salud. Gac Sanit. 2012; 26: 197-200 [AO,I]

22554457

ESALUD Y VÍDEOS ONLINE PARA LA PROMOCIÓN DE LA SALUD

 

Alonso-Blanco C, Palacios-Ceña D, Hernández-Barrera V, Carrasco-Garrido P, Jiménez-García R, Fernández-de-Las-Peñas C. Tendencias en la práctica de actividad física en el tiempo libre y el trabajo en la población española trabajadora, 1987-2006. Gac Sanit. 2012; 26: 223-230 [T,I]

22197322             R/C

TENDENCIAS EN LA PRÁCTICA DE ACTIVIDAD FÍSICA EN EL TIEMPO LIBRE Y EL TRABAJO EN LA POBLACIÓN ESPAÑOLA TRABAJADORA, 1987-2006

 

GUT

Bytzer P. New hope for functional dyspepsia? Gut. 2012; 61: 789-790 [AO,I]

22287593

¿NUEVA ESPERANZA PARA LA DISPEPSIA FUNCIONAL?

 

Young GP, Fraser CG, Halloran SP, Cole S. Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy? Gut. 2012; 61: 959-960 [AO,II]

22345655

PRUEBA DE SANGRE OCULTA EN HECES CON GUAYACO EN EL CRIBAJE DEL CÁNCER COLORRECTAL: ¿ESTRATEGIA OBSOLETA?

 

JOURNAL OF THE AMERICAN MEDICAL JOURNAL

Mohr DC, Ho J, Duffecy J, Reifler D, Sokol L, Burns MN, et al. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA. 2012; 307: 2278-2285 [EC,II]

22706833             R/C

EFECTO DE LA TERAPIA COGNITIVO-CONDUCTUAL POR TELEFONO FRENTE A CARA A CARA SOBRE EL SEGUIMIENTO DEL TRATAMIENTO Y LOS RESULTADOS EN LA DEPRESIÓN ENTRE LOS PACIENTES DE ATENCIÓN PRIMARIA: ENSAYO ALEATORIZADO

 

De Berardis G, Lucisano G, D'Ettorre A, Pellegrini F, Lepore V, Tognoni G, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA. 2012; 307: 2286-2294 [S,II]

22706834             R/C

ASOCIACIÓN DEL USO DE ASPIRINA CON SANGRADO IMPORTANTE EN PACIENTES CON Y SIN DIABETES

 

Siller-Matula JM. Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice? JAMA. 2012; 307: 2318-2320 [AO,I]

22706838

COMPLICACIONES HEMORRÁGICAS ASOCIADAS A LA ASPIRINA: ¿UN PELIGRO INFRAESTIMADO EN LA PRÁCTICA CLÍNICA?

 

Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012; 307: 2400-2409 [S,II]

22692172             R/C

USO DE ESTUDIOS DE DIAGNÓSTICO POR IMAGEN Y EXPOSICIÓN A LA RADIACIÓN ASOCIADA EN PACIENTES CUBIERTOS POR LOS GRANDES SISTEMAS INTEGRADOS DE ATENCIÓN SANITARIA

 

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307: 2418-2429 [M,II]

22610500             R/C

BENEFICIOS Y PERJUICIOS DE L CRIBAJE DE CÁNCER DE PULMÓN POR TAC: REVISIÓN SISTEMÁTICA

 

O'Connor GT, Hatabu H. Lung cancer screening, radiation, risks, benefits, and uncertainty. JAMA. 2012; 307: 2434-2435 [AO,I]

22692175

CRIBAJE DE CÁNCER DE PULMÓN, RADIACIÓN, RIESGOS, BENEFICIOS E INCERTIDUMBRE

 

Yu EW, Finkelstein JS. Bone density screening intervals for osteoporosis: one size does not fit all. JAMA. 2012; 307: 2591-2592 [AO,I]

22735425

LOS INTERVALOS DE CRIBAJE DE DENSIDAD ÓSEA PARA LA OSTEOPOROSIS: NO VALE EL MISMO PARA TODOS

 

Bray GA. Diet and exercise for weight loss. JAMA. 2012; 307: 2641-2642 [AO,I]

22735436

DIETA Y EJERCICIO PARA PERDER PESO

 

MEDICINA CLINICA

Tuells J, Arístegui J. Vacunaciones en la Ley General de Salud Pública: los 21 calendarios vacunales, suma y sigue. Med Clin (Barc). 2012; 139: 13-15  [AO,I]

22401735

VACUNACIONES EN LA LEY GENERAL DE SALUD PÚBLICA: LOS 21 CALENDARIOS VACUNALES, SUMA Y SIGUE

 

Martínez-Salio A. El reto del dolor neuropático. Med Clin (Barc). 2012; 139: 16-17 [AO,I]

22401728

EL RETO DEL DOLOR NEUROPÁTICO

 

Tudela P, Prat C, Lacoma A, Mòdol JM. Biomarcadores y sospecha de infección en los servicios de urgencias. Med Clin (Barc). 2012; 139: 33-37  [R,I]

22075231

BIOMARCADORES Y SOSPECHA DE INFECCIÓN EN LOS SERVICIOS DE URGENCIAS

 

Bruguera M, Calvo A. Preparándonos para la jubilación. Una responsabilidad individual y de los colegios profesionales. Med Clin (Barc). 2012; 139: 38-41 [AO,I]

22401738

PREPARÁNDONOS PARA LA JUBILACIÓN. UNA RESPONSABILIDAD INDIVIDUAL Y DE LOS COLEGIOS PROFESIONALES

 

Leonardo RC, Sospedra I, Sanchis I, Mañes J, Soriano JM. Comparación del somatotipo, evaluación nutricional e ingesta alimentaria entre estudiantes universitarios deportistas y sedentarios. Med Clin (Barc). 2012; 139: 54-60 [T,I]

21696787             R/C

COMPARACIÓN DEL SOMATOTIPO, EVALUACIÓN NUTRICIONAL E INGESTA ALIMENTARIA ENTRE ESTUDIANTES UNIVERSITARIOS DEPORTISTAS Y SEDENTARIOS

 

Roldán J, Morillas P, Quiles J, Castillo J, Andrade H, Bertomeu-Martínez V. Impacto del control de las cifras de presión arterial sobre el índice tobillo-brazo en el paciente hipertenso. Med Clin (Barc). 2012; 139: 61-64 [QE,I]

22538065             R/C

IMPACTO DEL CONTROL DE LAS CIFRAS DE PRESIÓN ARTERIAL SOBRE EL ÍNDICE TOBILLO-BRAZO EN EL PACIENTE HIPERTENSO

 

Miravitlles M. Inflamación, tabaco y enfermedad pulmonar obstructiva crónica. Demasiadas preguntas y pocas respuestas. Med Clin (Barc). 2012; 139: 65-66 [AO,I]

INFLAMACIÓN, TABACO Y ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA. DEMASIADAS PREGUNTAS Y POCAS RESPUESTAS

 

González-Juanatey JR. Hipertensión arterial y enfermedad arterial periférica. Una asociación peligrosa. Med Clin (Barc). 2012; 139: 67-69 [AO,I]

22534455

HIPERTENSIÓN ARTERIAL Y ENFERMEDAD ARTERIAL PERIFÉRICA. UNA ASOCIACIÓN PELIGROSA

 

Palma JA, Iriarte J. Regulación del apetito: bases neuroendocrinas e implicaciones clínicas. Med Clin (Barc). 2012; 139: 70-75 [R,I]

22257602             R/C

REGULACIÓN DEL APETITO: BASES NEUROENDOCRINAS E IMPLICACIONES CLÍNICAS

 

Castelló A, Francès F, Verdú F. Parte judicial de lesiones: uso y abuso. Med Clin (Barc). 2012; 139: 82-83 [AO,I]

22534452

PARTE JUDICIAL DE LESIONES: USO Y ABUSO

 

Rubio-Rivas M, Formiga F, Cuerpo S, Franco J, di Yacovo S, Martínez C, et al. Hiponatremia en pacientes ancianos ingresados en una Unidad de Agudos de Geriatría. Prevalencia y pronóstico. Med Clin (Barc). 2012; 139: 93-97 [T,I]

22401736             R/C

HIPONATREMIA EN PACIENTES ANCIANOS INGRESADOS EN UNA UNIDAD DE AGUDOS DE GERIATRÍA

 

Marco J, Zapatero A. La hiponatremia: un compañero ignorado. Med Clin (Barc). 2012; 139: 107-108 [AO,I]

22397983

LA HIPONATREMIA: UN COMPAÑERO IGNORADO

 

Giraldo P, Castells X. Responsabilidad sanitaria de la notificación de acontecimientos adversos: ¿puede estar tranquilo el profesional que notifica? Med Clin (Barc). 2012; 139: 109-111 [AO,I]

22401734

RESPONSABILIDAD SANITARIA DE LA NOTIFICACIÓN DE ACONTECIMIENTOS ADVERSOS: ¿PUEDE ESTAR TRANQUILO EL PROFESIONAL QUE NOTIFICA?

 

Cabrero L, de Abajo FJ, de la Fuente C, Serrano MA. Rutas administrativas y requisitos éticos y legales en la investigación biomédica con seres humanos en España: una guía para investigadores. Med Clin (Barc). 2012; 139: 118-125 [R,II]

22538064

RUTAS ADMINISTRATIVAS Y REQUISITOS ÉTICOS Y LEGALES EN LA INVESTIGACIÓN BIOMÉDICA CON SERES HUMANOS EN ESPAÑA: UNA GUÍA PARA INVESTIGADORES

 

Sanchis C, Vara LA. Cumplimiento terapéutico y seguimiento del paciente hipertenso en atención primaria. Med Clin (Barc). 2012; 139: 126-130 [AO,I]

22281095

CUMPLIMIENTO TERAPÉUTICO Y SEGUIMIENTO DEL PACIENTE HIPERTENSO EN ATENCIÓN PRIMARIA

 

Costa JA, Rodilla E, Cardona J, González C, Pascual JM. Síndrome metabólico y complicaciones cardiovasculares en el paciente hipertenso. Med Clin (Barc). 2012; 139: 150-156 [S,I]

21813141             R/C

SÍNDROME METABÓLICO Y COMPLICACIONES CARDIOVASCULARES EN EL PACIENTE HIPERTENSO

 

Valls T, Mach N. Riesgo de malnutrición en la población mayor de 75 años. Med Clin (Barc). 2012; 139: 157-160 [T,I]

22592079

RIESGO DE MALNUTRICIÓN EN LA POBLACIÓN MAYOR DE 75 AÑOS

 

Pérez-Llamas F. Riesgo de desnutrición en la población española de edad avanzada. Evaluación de la situación actual y necesidad de intervención nutricional. Med Clin (Barc). 2012; 139: 163-164 [AO,I]

22571850

RIESGO DE DESNUTRICIÓN EN LA POBLACIÓN ESPAÑOLA DE EDAD AVANZADA. EVALUACIÓN DE LA SITUACIÓN ACTUAL Y NECESIDAD DE INTERVENCIÓN NUTRICIONAL

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

Márquez-Contreras E, de la Figuera-Von Wichmann M, Franch-Nadal J, Llisterri-Caro JL, Gil-Guillén V, Martín-de Pablos JL, et al. ¿Los pacientes con alto riesgo vascular toman correctamente la medicación antihipertensiva? Estudio Cumple-MEMS. Rev Esp Cardiol. 2012; 65: 544-550 [S,I]

22520867             R/C

¿LOS PACIENTES CON ALTO RIESGO VASCULAR TOMAN CORRECTAMENTE LA MEDICACIÓN ANTIHIPERTENSIVA? ESTUDIO CUMPLE-MEMS

 

Guallar-Castillón P, Gil-Montero M, León-Muñoz LM, Graciani A, Bayán-Bravo A, Taboada JM, et al. Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008-2010: el estudio ENRICA. Rev Esp Cardiol. 2012; 65: 551-558 [T,I]

22483404             R/C

MAGNITUD Y MANEJO DE LA HIPERCOLESTEROLEMIA EN LA POBLACIÓN ADULTA DE ESPAÑA, 2008-2010: EL ESTUDIO ENRICA

 

Pappone C, Santinelli V. Tratamiento ablativo de la fibrilación auricular. Rev Esp Cardiol. 2012; 65: 560-569 [R,I]

22541284

TRATAMIENTO ABLATIVO DE LA FIBRILACIÓN AURICULAR

 

SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE

Nexøe J. Too much health care and too little care for the sick? Scand J Prim Health Care. 2012; 30: 62-63 [AO,I]

22643148

¿DEMASIADA ATENCIÓN SANITARIA Y DEMASIADA POCA ATENCIÓN PARA LOS ENFERMOS?

 

Moth G, Olesen F, Vedsted P. Reasons for encounter and disease patterns in Danish primary care: Changes over 16 years. Scand J Prim Health Care. 2012; 30: 70-75 [T,I]

22643150             R/C

RAZONES PARA LA CONSULTA Y PATRONES DE ENFERMEDAD EN LA ATENCIÓN PRIMARIA DANESA: CAMBIOS A LO LARGO DE 16 AÑOS

 

Rebnord IK, Sandvik H, Hunskaar S. Use of laboratory tests in out-of-hours services in Norway. Scand J Prim Health Care. 2012; 30: 76-80 [T,I]

22643151             R/C

USO DE LAS PRUEBAS DE LABORATORIO EN LOS SERVICIOS DE CONTINUIDAD EN NORUEGA

 

Rolandsson O, Norberg M, Nyström L, Söderberg S, Svensson M, Lindahl B, et al. How to diagnose and classify diabetes in primary health care: Lessons learned from the Diabetes Register in Northern Sweden (DiabNorth). Scand J Prim Health Care. 2012; 30: 81-87 [T,II]

22643152             R/C

CÓMO DIAGNOSTICAR Y CLASIFICAR LA DIABETES EN LA ATENCIÓN PRIMARIA SANITARIA: APRENDIZAJES DEL REGISTRO DE DIABETES DE SUECIA DEL NORTE

 

Korhonen P, Vesalainen R, Aarnio P, Kautiainen H, Järvenpää S, Kantola I. Assessment of cardiovascular risk in primary health care. Scand J Prim Health Care. 2012; 30: 101-106 [T,I]

22643155             R/C

VALORACIÓN DEL RIESGO CARDIOVASCULAR EN ATENCIÓN PRIMARIA SANITARIA

 

Kuikka L, Nevalainen MK, Sjöberg L, Salokekkilä P, Karppinen H, Torppa M, et al. The perceptions of a GP's work among fifth-year medical students in Helsinki, Finland. Scand J Prim Health Care. 2012; 30: 121-126 [T,I]

22339369             R/C

PERCEPCIONES DEL TRABAJO DE UN MÉDICO GENERAL ENTRE LOS ESTUDIANTES DE MEDICINA DE QUINTO AÑO EN HELSINKI, FINLANDIA

 

THE LANCET

To screen or not to screen for prostate cancer? Lancet. 2012; 379: 2024 [AO,I]

¿CRIBAR O NO CRIBAR EL CÁNCER DE PRÓSTATA?

 

Nambi V, Pedroza C, Kao LS. Carotid intima-media thickness and cardiovascular events. Lancet. 2012; 379: 2028-2030 [AO,I]

22541276

ESPESOR DE LA ÍNTIMA-MEDIA CAROTÍDEA Y ACONTECIMIENTOS CARDIOVASCULARES

 

Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Völzke H, Tuomainen TP, et al; PROG-IMT Study Group. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet. 2012; 379: 2053-2062 [M,II]

22541275             R/C

PROGRESIÓN DEL ESPESOR DE LA ÍNTIMA-MEDIA CAROTÍDEA PARA PREDECIR LOS ACONTECIMIENTOS CARDIOVASCULARES EN LA POBLACIÓN GENERAL (PROYECTO DE COLABORACIÓN PROGR-IMT): METAANÁLISIS DE DATOS DE LOS PARTICIPANTES INDIVIDUALES

 

Chan M, Lake A. Towards ending preventable child deaths. Lancet. 2012; 379: 2119-2120 [AO,I]

22682447

HACIA EL FIN DE LAS MUERTES INFANTILES PREVENIBLES

 

Countdown  2012 Report Writing Group. Building a future for women and children. Lancet. 2012; 379: 2121-2122 [AO,I]

22682448

CONSTRUIR UN FUTURO PARA LAS MUJERES Y LOS NIÑOS

 

Gupta GR. Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children. Lancet. 2012; 379: 2123-2124 [AO,I]

22682449

ENFRENTARSE A LA NEUMONÍA Y LA DIARREA: LAS ENFERMEDADES MÁS MORTALES DE LOS NIÑOS MÁS POBRES DEL MUNDO

 

Presern C, Bustreo F, Droop J, Fogstad H, Starrs A, Axelson H, et al. Keeping promises for women and children. Lancet. 2012; 379: 2125-2126 [AO,I]

22682450

MANTENER LAS PROMESAS A LAS MUJERES Y LOS NIÑOS

 

Bhutta ZA. Global child survival: beyond numbers. Lancet. 2012; 379: 2126-2128 [AO,I]

22579124

SUPERVIVENCIA INFANTIL EN EL MUNDO: MÁS ALLÁ DE LOS NÚMEROS

 

Morken NH. Preterm birth: new data on a global health priority. Lancet. 2012; 379: 2128-2130 [AO,I]

22682451

PARTO PRETÉRMINO: NUEVOS DATOS SOBRE UNA PRIORIDAD SANITARIA MUNDIAL

 

Orenstein WA, Hinman AR. Measles: the burden of preventable deaths. Lancet. 2012; 379: 2130-2131 [AO,I]

22534000

SARAMPIÓN: CARGA DE MUERTES PREVENIBLES

 

Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379: 2151-2161 [M,II]

22579125             R/C

CAUSAS NACIONALES, REGIONALES Y MUNDIALES DE MORTALIDAD INFANTIL: ANÁLISIS SISTEMÁTICO ACTUALIZADO DE 2010 CON TENDENCIAS TEMPORALES DESDE 2000

 

Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012; 379: 2162-2172 [M,II]

22682464             R/C

ESTIMACIONES NACIONALES, REGIONALES Y MUNDIALES DE LAS TASAS DE PARTOS PRETÉRMINO EN EL AÑO 2010 CON TENDENCIAS TEMPORALES DESDE 1990 EN PAÍSES SELECCIONADOS: ANÁLISIS SISTEMÁTICO E IMPLICACIONES

 

Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012; 379: 2173-2178 [T,I]

22534001             R/C

VALORACIÓN DEL OBJETIVO DE REDUCCIÓN DE MORTALIDAD MUNDIAL POR SARAMPIÓN EN 2010: RESULTADOS DE UN MODELO DE DATOS DE VIGILANCIA

 

Prediabetes and the potential to prevent diabetes. Lancet. 2012; 379: 2213 [AO,I]

22704153

PREDIABETES Y POTENCIAL PARA PREVENIR LA DIABETES

 

Gonorrhoea--old disease, new threat. Lancet. 2012; 379: 2214 [AO,I]

22704155

GONORREA: VIEJA ENFERMEDAD, NUEVA AMENAZA

 

Diamant M. Choosing a blood-glucose-lowering agent after metformin. Lancet. 2012; 379: 2220-2221 [AO,I]

22683135

ELEGIR UN AGENTE REDUCTOR DE LA GLUCEMIA TRAS LA METFORMINA

 

Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012; 379: 2243-2251 [EC,II]

22683134             R/C

EFECTO DE LA REGRESIÓN DESDE LA PREDIABETES A LA REGULACIÓN NORMAL DE LA GLUCOSA SOBRE LA REDUCCIÓN DEL RIESGO DE DIABETES A LARGO PLAZO: RESULTADOS DEL ESTUDIO DIABETES PREVENTION PROGRAM OUTCOMES

 

Aschner P, Chan J, Owens DR, Picard S, Wang E, Dain MP, Pilorget V, et al; EASIE investigators. Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial. Lancet. 2012; 379: 2262-2269 [EC,II]

22683131             R/C

INSULINA GLARGINA FRENTE A SITAGLIPTINA EN PACIENTES CON DIABETES MELLITUS TIPO 2 NO CONTROLADOS CON METFORMINA Y QUE NUNCA HAN RECIBIDO INSULINA (EASIE): ENSAYO MULTICÉNTRICO ALEATORIZADO SIN ENMASCARAR

 

Gallwitz B, Guzman J, Dotta F, Guerci B, Simó R, Basson BR, et al. Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial. Lancet. 2012; 379: 2270-2278 [EC,I]

22683137             R/C

EXENATIDA DOS VECES AL DÍA FRENTE A GLIMEPIRIDA EN LA PREVENCIÓN DEL DETERIORO GLUCÉMICO EN PACIENTES CON DIABETES TIPO 2 CON FRACASO DE LA METFORMINA (EUREXA): ENSAYO CONTROLADO ALEATORIZADO NO ENMASCARADO

 

Suicide prevention: steps to be taken. Lancet. 2012; 379: 2314 [AO,I]

22726499

PREVENCIÓN DEL SUICIDIO: PASOS A DAR

 

Leys D, Cordonnier C. rt-PA for ischaemic stroke: what will the next question be? Lancet. 2012; 379: 2320-2321 [AO,I]

22632906

rt-PA EN EL ICTUS ISQUÉMICO: ¿CUÁL SERÁ LA PRÓXIMA CUESTIÓN?

 

Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012; 379: 2364-2372 [M,II]

22632907             R/C

ACTIVADOR DEL PLASMINÓGENO TISULAR RECOMBINANTE EN EL ICTUS ISQUÉMICO AGUDO: REVISIÓN SISTEMÁTICA ACTUALIZADA Y METAANÁLISIS

 

THE NEW ENGLAND JOURNAL OF MEDICINE

Iglehart JK. Primary care update--light at the end of the tunnel? N Engl J Med. 2012; 366: 2144-2146 [AO,I]

22621420

ACTUALIZACIÓN EN ATENCIÓN PRIMARIA -- ¿LUZ AL FINAL DEL TÚNEL?

 

DeVita VT Jr, Rosenberg SA. Two hundred years of cancer research. N Engl J Med. 2012; 366: 2207-2214 [R,II]

22646510

DOSCIENTOS AÑOS DE INVESTIGACIÓN DEL CÁNCER

 

Chaisson RE, Nuermberger EL. Confronting multidrug-resistant tuberculosis. N Engl J Med. 2012; 366: 2223-2224 [AO,I]

22670908

ENFRENTARSE  A LA TUBERCULOSIS CON MULTIRRESISTENCIA FARMACOLÓGICA

 

Mandl KD, Kohane IS. Escaping the EHR trap--the future of health IT. N Engl J Med. 2012; 366: 2240-2242 [AO,I]

22693995

ESCAPAR DE LA TRAMPA DE LA HISTORIA CLÍNICA ELECTRÓNICA -- EL FUTURO DE LAS TECNOLOGÍAS DE LA INFORMACIÓN EN SALUD

 

Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, et al;TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012; 366: 2247-2256 [EC,I]

22540912             R/C

ENSAYO CLÍNICO PARA MANTENER EL CONTROL GLUCÉMICO EN JÓVENES CON DIABETES TIPO 2

 

Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012; 366: 2257-2266 [S,II]

22693997             R/C

ICTUS TROMBÓTICO E INFARTO DE MIOCARDIO CON LA ANTICONCEPCIÓN HORMONAL

 

Downing NS, Aminawung JA, Shah ND, Braunstein JB, Krumholz HM, Ross JS. Regulatory review of novel therapeutics--comparison of three regulatory agencies. N Engl J Med. 2012; 366: 2284-2293 [T,I]

22591257             R/C

REVISIÓN REGULATORIA DE LAS TERAPÉUTICAS NOVEDOSAS-- COMPARACIÓN DE TRES ORGANISMOS  REGULADORES

 

Petitti DB. Hormonal contraceptives and arterial thrombosis--not risk-free but safe enough. N Engl J Med. 2012; 366: 2316-2318 [AO,I]

22694003

ANTICONCEPTIVOS HORMONALES Y TROMBOSIS ARTERIAL--NO LIBRES DE RIESGO PERO SUFICIENTEMENTE SEGUROS

 

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012; 366: 2345-2357 [EC,I]

22612596             R/C

INCIDENCIA Y MORTALIDAD POR CÁNCER COLORRECTAL CON EL CRIBAJE MEDIANTE SIGMOIDOSCOPIO FLEXIBLE

 

_____

 

ACADEMIC MEDICINE

 

S22534593

 

Despite the national priority to eliminate health disparities, more than half of national physician organizations are doing little to address this problem. Primary care and minority physician organizations, and those with disparities committees, may provide leadership to extend the scope of disparity-reduction efforts.

S22534597

 

Motivational processes may be a substantially undervalued factor in curriculum development. Building curricula to specifically stimulate motivation in students may powerfully influence the outcomes of curricula. The elements essential for stimulating intrinsic motivation in students, including autonomy support, adequate feedback, and emotional support, appear lacking as a primary aim in many curricular plans.

S22643375

 

A research report in this issue of Academic Medicine by Peek and colleagues describes how physician organizations are mounting different initiatives targeted at reducing health disparities. The study emphasizes how these organizations are attempting to promote health equity through policies and programs focused on education, clinical care, research, and advocacy. They found that 68% of surveyed organizations have at least one initiative targeting health disparities.This commentary acknowledges the positive trend uncovered by Peek and colleagues which characterizes the engagement level of national physician organizations on this critical issue, and suggests four ways to enhance future efforts. First, health equity should be linked to overall quality of care and emerging initiatives aimed at transforming the delivery of health care. Second, the effect of such efforts can be magnified by evaluating what works and sharing best practices. Third, interventions must be targeted at institutions as well as individual physicians. Finally, it should be emphasized that the driving rationale for physicians to strive for health equity is the ethical imperative to promote justice in health care.

 

CIRCULATION

 

S22572915

Increased arterial stiffness and impaired endothelial function are significant correlates of a higher exercise systolic BP response. Our findings suggest that impaired vascular function may contribute to exaggerated BP responses during daily living, resulting in repetitive increments in load on the heart and vessels and increased cardiovascular disease risk.

S22623717

Chest compression rate was associated with return of spontaneous circulation but not with survival to hospital discharge in OOH cardiac arrest.

 

ARCHIVOS DE BRONCONEUMOLOGIA

 

S22421522

Nuestro objetivo fue evaluar la asociación entre tos crónica y las variables que pudieran incidir en el curso de la tos, con objeto de extraer un perfil del tosedor de peor respuesta. En nuestra unidad de tos crónica 192 pacientes fueron seguidos prospectivamente durante 3 meses, durante los que se valoraron y trataron todas las variables que pudieran influir en el reflejo de la tos. La mejoría de la tos se evaluó por la respuesta del paciente ante una escala visual analógica con puntuaciones de 0 a 4, considerándose el valor 0 como «sin cambios», y como mejoría una puntuación en la escala de 3 o 4. Se consideró tos de escasa respuesta si persistía sin mejoría más allá de los 3 meses. Mediante un modelo de regresión logística multivariante se introdujeron variables candidatas a estar asociadas a la mejoría de la tos a los 3 meses. En el modelo final del perfil del tosedor de mal pronóstico permanecen 3 variables: sexo, reflujo gastroesofágico típico y trastorno psicosocial. Ser hombre está asociado con una mejoría de la tos a los 3 meses (OR=2,10, IC95%: 1,00-4,38). Sin embargo, presentar reflujo gastroesofágico está asociado con una reducción de la mejoría a los 3 meses en un 55% (OR=0,45, IC95%: 0,24-0,84), y padecer un trastorno psicosocial disminuye la probabilidad de mejoría de la tos a los 3 meses en un 70% (OR=0,30, IC95%: 0,09-1,03).

S22385832

A pesar de que las recomendaciones de las principales guías clínicas han restringido las indicaciones de los corticoides inhalados en la enfermedad pulmonar obstructiva crónica (EPOC), actualmente más del 80% de los pacientes están recibiendo este tratamiento en España, en su mayoría con dosis elevadas. Una revisión detallada de la literatura no justifica el uso de estas dosis elevadas, posicionamiento que está de acuerdo con las recomendaciones de la FDA. Una revaloración de su seguridad, la consistencia de los datos de eficacia, que muestran resultados similares con dosis moderadas, y una mejor selección de los pacientes exige un replanteamiento del uso de este tratamiento en el paciente con EPOC.

 

BRITISH JOURNAL OF PSYCHIATRY

 

S22322459

Alcohol dependence, especially severe current dependence, is a risk factor for an unfavourable course of depressive and/or anxiety disorders, whereas alcohol abuse is not.

S22539780

In the management of functional somatic syndromes, a cognitive-behavioural group treatment was more effective than enhanced usual care.

S22661676

Functional somatic symptoms associated with persistent frequent attendance is emotionally demanding, costly and intractable to treat. Such patients are hard to engage in practice and research by mental health professionals, whose main role may be indirect training, supporting and advising primary care professionals rather than direct patient care.

 

DRUGS

 

S22686617

Bilastine is an orally administered, second-generation antihistamine used in the symptomatic treatment of seasonal or perennial allergic rhinoconjunctivitis and urticaria. In two well designed phase III trials, 14 days' treatment with bilastine was associated with a significantly lower area under the effect curve (AUEC) for the reflective total symptom score (TSS) than placebo in patients with symptomatic seasonal allergic rhinitis. Additionally, reflective nasal symptom scores were significantly lower in bilastine than placebo recipients in patients with a history of seasonal allergic rhinitis who were challenged with grass pollen allergen in a single-centre, phase II study. Neither bilastine nor cetirizine was effective in the treatment of perennial allergic rhinitis with regard to the mean AUEC for reflective TSS in another well designed phase III trial. However, results may have been altered by differences in some baseline characteristics and placebo responses between study countries. In another well designed phase III trial, compared with placebo, bilastine was associated with a significantly greater change from baseline to day 28 in the mean reflective daily urticaria symptom score in patients with chronic urticaria. There were no significant differences in primary endpoint results between bilastine and any of the active comparators used in these trials (i.e. cetirizine, levocetirizine and desloratadine). Bilastine was generally well tolerated, with a tolerability profile that was generally similar to that of the other second-generation antihistamines included in phase III clinical trials.

S22568730

The corticosteroid mometasone and the long-acting ß(2)-selective adrenoreceptor agonist formoterol have been combined in a single pressurized metered-dose inhaler for use in patients aged =12 years with asthma. In a 26-week well designed trial in patients with persistent asthma uncontrolled on medium-dose inhaled corticosteroids (ICS), mometasone/formoterol 200?µg/10?µg twice daily (bid) was more effective than placebo or the same nominal dosage of formoterol alone in reducing the incidence of asthma deteriorations, as well as in improving lung function, asthma control, asthma symptoms and asthma-related quality-of-life outcomes. The combination was also more effective than the same nominal dosage of mometasone alone in improving lung function and asthma control. Similarly, in a 12-week well designed trial in patients with persistent asthma uncontrolled on high-dose ICS, mometasone/formoterol 400?µg/10?µg bid was more effective than the same nominal dosage of mometasone alone in improving lung function, asthma control and asthma symptoms. Treatment with a lower dosage of the combination (200?µg/10?µg bid) yielded similar results and, moreover, significantly reduced the incidence of asthma deteriorations compared with mometasone alone. Mometasone/formoterol was generally well tolerated in clinical trials of 12-52 weeks' duration. The adverse event profile of the combination was consistent with that of its individual components; no new or unexpected safety signals were detected.

 

EUROPEAN HEART JOURNAL

 

S22634577

Antisense oligonucleotides (ASOs) are short synthetic analogues of natural nucleic acids designed to specifically bind to a target messenger RNA (mRNA) by Watson-Crick hybridization, inducing selective degradation of the mRNA or prohibiting translation of the selected mRNA into protein. Antisense technology has the ability to inhibit unique targets with high specificity and can be used to inhibit synthesis of a wide range of proteins that could influence lipoprotein levels and other targets. A number of different classes of antisense agents are under development. To date, mipomersen, a 2'-O-methoxyethyl phosphorothioate 20-mer ASO, is the most advanced ASO in clinical development. It is a second-generation ASO developed to inhibit the synthesis of apolipoprotein B (apoB)-100 in the liver. In Phase 3 clinical trials, mipomersen has been shown to significantly reduce plasma low-density lipoprotein cholesterol (LDL-c) as well as other atherogenic apoB containing lipoproteins such as lipoprotein (a) [Lp(a)] and small-dense LDL particles. Although concerns have been raised because of an increase in intrahepatic triglyceride content, preliminary data from long-term studies suggest that with continued treatment, liver fat levels tend to stabilize or decline. Further studies are needed to evaluate potential clinical relevance of these changes. Proprotein convertase subtilisin/kexin-9 (PCSK9) is another promising novel target for lowering LDL-c by ASOs. Both second-generation ASOs and ASOs using locked nucleic acid technology have been developed to inhibit PCSK9 and are under clinical development. Other targets currently being addressed include apoC-III and apo(a) or Lp(a). By directly inhibiting the synthesis of specific proteins, ASO technology offers a promising new approach to influence the metabolism of lipids and to control lipoprotein levels. Its application to a wide variety of potential targets can be expected if these agents prove to be clinically safe and effective.

S22246443

Several independent risk factors (prior ICH, myocardial infarction, vascular disease, and renal failure) predict ischaemic stroke and/or the composite thromboembolism endpoint in AF, but thyroid disease (or hyperthyroidism) was not an independent risk factor for stroke. There is a better performance for CHA(2)DS(2)-VASc over CHADS(2) schemes for the composite thromboembolism endpoint. While both tested bleeding risk schemes have similar predictive value, the HAS-BLED score has the advantage of simplicity.

 

FAMILY MEDICINE

 

S22733421

 

With preparation for, practice, and feedback on leading mini-GMVs, family medicine residents demonstrated improved skills for conducting GMVs.

S22733420

 

We found broad areas of consensus regarding information PCPs wish to receive about their hospitalized patients that are generally consistent with previous surveys. Our findings also suggest that physicians are becoming more comfortable with patient-related electronic communications.

S22733418

 

A minority of patients with STI symptoms were empirically treated. Outpatient clinicians should consider whether a patient meets guidelines for empiric STI treatment; this decision should take into account the feasibility of prompt follow-up. This may be especially important in women presenting with STI symptoms.

 

GACETA SANITARIA

 

S22197322

La práctica de AFTL y AFTT ha aumentado significativamente en los últimos 20 años en la población trabajadora española. Diferentes factores se asocian a una mayor o menor práctica de AFTL y AFTT en esta población.

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

S22520867

 

Entre los hipertensos de alto riesgo vascular, el incumplimiento fue muy alto, fundamentalmente cuando toman cinco o más comprimidos diarios.

S22483404

 

Aproximadamente la mitad de los españoles tienen colestererolemia elevada; el control del colesterol es pobre, particularmente en aquellos con mayor riesgo cardiovascular, como los diabéticos o los enfermos cardiovasculares.

 

SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE

 

S22339369

 

Medical students may have perceptions of the GP's work that influence their career choices to specialize in other fields.

S22643151

 

CRP is extensively used in OOH services, especially by young and inexperienced doctors, and in central areas. Further investigations are required to see if this extensive use of CRP is of importance for correct diagnosis and treatment

S22643155

 

The SCORE system does not take into account cardiovascular risk factors typical in women, and thus underestimates their total cardiovascular risk. Measurement of ABI and eGFR in primary care might improve cardiovascular risk assessment. especially in women.

S22643152

 

It was concluded that it is feasible to create a diabetes register based on information in medical records in general practice. However, special attention should be paid to the validity of the diabetes diagnosis and its classification.

S22643150

 

Quite small changes were seen in the patterns of reasons for encounter and diagnoses from 1993 to 2009. However, an increase was found in contacts with general practice and referrals and in the proportion of follow-ups.

 

ANNALS OF INTERNAL MEDICINE

 

S22711079

 

Overall, drugs for urgency UI showed similar small benefit. Therapeutic choices should consider the harms profile. Evidence for long-term adherence and safety of treatments is lacking.

S22711077

 

Approximately 1 in 8 hospitalized patients with AD who develop delirium will have at least 1 adverse outcome, including death, institutionalization, or cognitive decline, associated with delirium. Delirium prevention may represent an important strategy for reducing adverse outcomes in this population.

S22711076

 

Danish patients with alcoholic cirrhosis have a low risk for HCC, and HCC contributes little to their high mortality. On the basis of these data, HCC surveillance would be expected to have a minimal effect on mortality and is unlikely to be cost-effective.

S22711081

 

This recommendation statement applies to women who have a cervix, regardless of sexual history. This recommendation statement does not apply to women who have received a diagnosis of a high-grade precancerous cervical lesion or cervical cancer, women with in utero exposure to diethylstilbestrol, or women who are immunocompromised (such as those who are HIV positive).The USPSTF recommends screening for cervical cancer in women aged 21 to 65 years with cytology (Papanicolaou smear) every 3 years or, for women aged 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and HPV testing every 5 years. See the Clinical Considerations for discussion of cytology method, HPV testing, and screening interval (A recommendation).The USPSTF recommends against screening for cervical cancer in women younger than age 21 years (D recommendation).The USPSTF recommends against screening for cervical cancer in women older than age 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer. See the Clinical Considerations for discussion of adequacy of prior screening and risk factors (D recommendation).The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial neoplasia grade 2 or 3) or cervical cancer (D recommendation).The USPSTF recommends against screening for cervical cancer with HPV testing, alone or in combination with cytology, in women younger than age 30 years (D recommendation).

S22565034

 

Screening instruments accurately identify women experiencing IPV. Screening women for IPV can provide benefits that vary by population, while potential adverse effects have minimal effect on most women

S22312131

 

Neither the CKD-EPI nor the MDRD Study equation is optimal for all populations and GFR ranges. Using a single equation for reporting requires a tradeoff to optimize performance at either higher or lower GFR ranges. A general practice and public health perspective favors the CKD-EPI equation

 

ATENCION PRIMARIA

 

S22088774

Realizar espirometría en fumadores de alto riesgo, mostrar los resultados espirométricos y consejo breve antitabaco permite detectar a casos de EPOC no diagnosticados previamente, ver su predisposición a dejar el tabaco y establecer un plan de tratamiento y seguimiento individualizado.

S22608367

Recomendaciones PAPPS 2012 para el cribado cáncer de mama con mamografía en población de riesgo medio – La mamografía de cribado no debería recomendarse a la mujeres de 40 a 49 años (evidencia moderada; recomendación débil en contra) – La mamografía de cribado debería recomendarse a las mujeres de 50 a 69 años cada 2 años (evidencia moderada; recomendación débil a favor) – La mamografía de cribado debería recomendarse a las mujeres de 70 a 74 años cada...

S21871691

El cuestionario VIDA es una herramienta muy fiable, sin presentar sesgo de género. Su medición se asocia con la de otras medidas de funcionalidad y con factores de fragilidad en el anciano.

 

ARCHIVES OF INTERNAL MEDICINE

 

S22688992

Smoking remains a strong risk factor for premature mortality also at older age. Smoking cessation is beneficial at any age.

S22732749

Atypical femoral fractures were associated with bisphosphonate use; longer duration of treatment resulted in augmented risk. The incidence of atypical fractures increased over a 12-year period, but the absolute number of such fractures is very small.

S22732744

Statin therapy is an effective intervention in the secondary prevention of cardiovascular events in both sexes, but there is no benefit on stroke and all-cause mortality in women.

 

ARCHIVES OF GENERAL PSYCHIATRY

 

S22393205

To our knowledge, this is the first research synthesis in this area to use complete longitudinal person-level data from a large set of published and unpublished studies. The results do not support previous findings that antidepressants show little benefit except for severe depression. The antidepressants fluoxetine and venlafaxine are efficacious for major depressive disorder in all age groups, although more so in youths and adults compared with geriatric patients. Baseline severity was not significantly related to degree of treatment advantage over placebo.

S22309970

Compared with never smokers, middle-aged male smokers experienced faster cognitive decline in global cognition and executive function. In ex-smokers with at least a 10-year cessation, there were no adverse effects on cognitive decline.

 

DIABETES CARE

 

S22432104

Once-daily lixisenatide monotherapy significantly improved glycemic control with a pronounced postprandial effect (75% reduction in glucose excursion) and was safe and well tolerated in type 2 diabetes.

S22432119

Risk of death can be predicted in people with type 2 diabetes using simple demographic, socioeconomic, and biological risk factors with fair reliability. Such prediction equations are essential for computer simulation models of diabetes progression and may, with further validation, be useful for patient management.

S22511257

Medication noncompliance and clinic nonattendance, assessed during routine care by primary care physicians or their staff, were independently associated with increased all-cause mortality in patients with type 2 diabetes receiving insulin.

S22619288

Death rates among both U.S. men and women with diabetes declined substantially between 1997 and 2006, reducing the absolute difference between adults with and without diabetes. These encouraging findings, however, suggest that diabetes prevalence is likely to rise in the future if diabetes incidence is not curtailed.

S22538012

Participant reports of family members' nonsupportive behaviors were associated with being less adherent to one's diabetes medication regimen. Participants emphasized the importance of instrumental help for diabetes self-care behaviors and reported that nonsupportive family behaviors sabotaged their efforts to perform these behaviors. Interventions should inform family members about diabetes and enhance their motivation and behavioral skills around not interfering with one's diabetes self-care efforts.

 

FAMILY PRACTICE

 

S22006040

 

GPs are conditionally willing to use new consultation media if clinically appropriate and if medico-legal and technical support is available.

S22308180

 

There is a lot of congruence in diagnostic process and concepts between populations, across age groups, years of observation and FD practices, despite differences in the strength of such diagnostic associations. There is particularly little variability of diagnostic ORs across years of observation and between individual FD practices. Given our findings, it makes sense to aggregate diagnostic data from different FD practices and years of observation. Our findings support the existence of common core diagnostic concepts in international FM.

S22308182

 

Data that are collected with an episode-based model define incidence and prevalence rates much more precisely. Incidence and prevalence rates reflect the content of the doctor-patient encounter in FM but only from a superficial perspective. However, we found evidence of an international FM core content and a local FM content reflected by important similarities in such distributions. FM is a complex discipline, and the reduction of the content of a consultation into one or more medical diagnoses, ignoring the patient's RfE, is a coarse reduction, which lacks power to fully characterize a population's health care needs. In fact, RfE distributions seem to be more consistent between populations than distributions of EoCs are, in many respects.

S22308178

 

ICPC, the RfE and the EoC data model are appropriate tools to study the process of diagnosis in FM. Distributions of diagnostic associations between RfEs and episode titles in the Transition Project international populations show remarkable similarities and congruencies in the process of diagnosis from both the RfE and the episode title perspectives. The congruence of diagnostic associations between populations supports the use of such data from one population to inform diagnostic decisions in another. Differences in the magnitude of such diagnostic associations are significant, and population-specific data are therefore desirable. We propose that both an international (common) and a local (health care system specific) content of FM exist and that the empirical distributions of diagnostic associations presented in this paper are a reflection of both these effects. We also observed that the frequency of exposure to such diagnostic challenges had a strong effect on the confidence intervals of diagnostic ORs reflecting these diagnostic associations. We propose that this constitutes evidence that expertise in FM is associated with frequency of exposure to diagnostic challenges.

S22024665

 

Findings in general practice and at the Department of Nuclear Medicine were concordant with regard to the threshold value of ABI 0.9. However, this study does not warrant a recommendation of doppler measurements or assessment of ABI as screening or diagnostic procedure due to low specificity of assessments in general practice. Our results indicate a high number of false-positive tests if the method is applied for screening in general practice.

S22045931

 

The identified themes appear to be core elements of care to patients. Thus, it may be valuable to develop an instrument to measure these three common themes universally. In the patient-centred medical home, such an instrument might turn out to be an important quality measure, which will enable researchers and policy makers to compare care settings and practices and to evaluate new care interventions from the patient perspective.

S22016323

 

Identification of attitudes/knowledge related with inappropriate antibiotic prescribing will enable specific interventions to be designed, with the aim of targeting these shortcomings to improve antibiotic use and help reduce resistance

S22016322

 

FPs believe to have sensible strategies for diagnosing depression that are different from the concepts operationalized in psychiatrically oriented classifications. In diagnostic studies, considering standardized psychiatric interviews uncritically as a gold standard for diagnosis of depression in primary care might be misleading.

S22308181

 

This is a review of the literature on the role of symptoms in family practice, with a focus on the diagnostic approach in family medicine (FM). We found two, contrasting, approaches to reducing symptoms presented by patients in primary care, especially those which do not immediately allow the definition of a disease-label diagnosis. Years of research into 'medically unexplained symptoms' (MUS) has failed to support an international body of knowledge and cannot convincingly support the philosophy on which the reduction itself is based. This review supports the approach of researching reasons for encounter as they present to the family doctor, without artificial mind-body metaphors. The medical model is shown to be an incomplete reduction of FM, and the concept of MUS fails to improve this situation. A new model based on a substantial paradigm shift is needed. That model should be the biopsychosocial model, reflected in the philosophical concepts of the International Classification of Primary Care and the value of the patient's 'reason for encounter'. There is more to life than medicine may diagnose, and FM should strive to move closer to the lives of our patients than the medical model alone could allow.

 

JOURNAL OFTHEAMERICAN MEDICAL JOURNAL

 

S22706834

In a population-based cohort, aspirin use was significantly associated with an increased risk of major gastrointestinal or cerebral bleeding episodes. Patients with diabetes had a high rate of bleeding that was not independently associated with aspirin use.

S22610500

Low-dose computed tomography screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalizability of results.

S22692172

Within integrated health care systems, there was a large increase in the rate of advanced diagnostic imaging and associated radiation exposure between 1996 and 2010.

S22706833

Among primary care patients with depression, providing CBT over the telephone compared with face-to-face resulted in lower attrition and close to equivalent improvement in depression at posttreatment. At 6-month follow-up, patients remained less depressed relative to baseline; however, those receiving face-to-face CBT were less depressed than those receiving T-CBT. These results indicate that T-CBT improves adherence compared with face-to-face delivery, but at the cost of some increased risk of poorer maintenance of gains after treatment cessation.

 

THE LANCET

 

S22541275

 

The association between cIMT progression assessed from two ultrasound scans and cardiovascular risk in the general population remains unproven. No conclusion can be derived for the use of cIMT progression as a surrogate in clinical trials.

S22534001

 

Despite rapid progress in measles control from 2000 to 2007, delayed implementation of accelerated disease control in India and continued outbreaks in Africa stalled momentum towards the 2010 global measles mortality reduction goal. Intensified control measures and renewed political and financial commitment are needed to achieve mortality reduction targets and lay the foundation for future global eradication of measles.

S22683137

 

These findings provide evidence for the benefits of exenatide versus glimepiride for control of glycaemic deterioration in patients with type-2 diabetes inadequately controlled by metformin alone.

S22579125

 

Child survival strategies should direct resources toward the leading causes of child mortality, with attention focusing on infectious and neonatal causes. More rapid decreases from 2010-15 will need accelerated reduction for the most common causes of death, notably pneumonia and preterm birth complications. Continued efforts to gather high-quality data and enhance estimation methods are essential for the improvement of future estimates.

S22683134

 

We conclude that prediabetes is a high-risk state for diabetes, especially in patients who remain with prediabetes despite intensive lifestyle intervention. Reversion to normal glucose regulation, even if transient, is associated with a significantly reduced risk of future diabetes independent of previous treatment group.

S22683131

 

Our results support the option of addition of basal insulin in patients with type 2 diabetes inadequately controlled by metformin. Long-term benefits might be expected from the achievement of optimum glycaemic control early in the course of the disease.

S22682464

The burden of preterm birth is substantial and is increasing in those regions with reliable data. Improved recording of all pregnancy outcomes and standard application of preterm definitions is important. We recommend the addition of a data-quality indicator of the per cent of all live preterm births that are under 28 weeks' gestation. Distinguishing preterm births that are spontaneous from those that are provider-initiated is important to monitor trends associated with increased caesarean sections. Rapid scale up of basic interventions could accelerate progress towards Millennium Development Goal 4 for child survival and beyond.

S22632907

The evidence indicates that intravenous rt-PA increased the proportion of patients who were alive with favourable outcome and alive and independent at final follow-up. The data strengthen previous evidence to treat patients as early as possible after acute ischaemic stroke, although some patients might benefit up to 6 h after stroke.

 

MEDICINA CLINICA

 

S22401736

 

Hyponatremia in patients admitted in an AGU is a prevalent disorder related with a greater hospital length of stay, but not with mortality.

S21696787

 

Los desequilibrios tanto en macronutrientes como en micronutrientes reflejan la importancia de desarrollar adecuadas políticas de educación alimentaria universitaria que pueden mejorar esta situación.

S22538065

 

Un adecuado control de la PA se asocia con un aumento del valor del ITB tras un año de seguimiento.

S22257602

 

El control de la ingesta y del metabolismo energético depende de complejas interacciones entre los sistemas que regulan la homeostasis energética, el control hedonista de la ingesta y las señales que provienen de los sentidos. Gracias a estudios experimentales en animales y a la observación de pacientes con trastornos de la conducta alimentaria, se está avanzando significativamente en el conocimiento de la regulación del apetito. El hipotálamo es la región cerebral clave en el control de la alimentación. Las múltiples regiones hipotalámicas envían y reciben señales procedentes de la ínsula, la corteza orbitofrontal, el núcleo accumbens y el sistema de recompensa dopaminérgico, así como señales químicas, incluyendo péptidos y hormonas gastrointestinales, para regular la conducta alimentaria. Investigaciones recientes muestran la compleja interacción entre los mecanismos homeostáticos y hedonistas de la ingesta, compartiendo mecanismos neurobiológicos con las adicciones. La identificación de dianas terapéuticas hará posible el desarrollo de fármacos eficaces para el tratamiento de los trastornos de la conducta alimentaria, como la obesidad.

S21813141

 

El diagnóstico de SM no mostró una aportación significativa a los factores clásicos de riesgo cardiovascular como predictor de ECV, en hipertensos no diabéticos en prevención primaria. La presión arterial sistólica =160mm Hg y el colesterol LDL =160mg/dl durante el seguimiento sí que se asociaron a la aparición de ECV.

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

S22540912

 

Monotherapy with metformin was associated with durable glycemic control in approximately half of children and adolescents with type 2 diabetes. The addition of rosiglitazone, but not an intensive lifestyle intervention, was superior to metformin alone.

S22612596

 

Screening with flexible sigmoidoscopy was associated with a significant decrease in colorectal-cancer incidence (in both the distal and proximal colon) and mortality (distal colon only).

S22693997

 

Although the absolute risks of thrombotic stroke and myocardial infarction associated with the use of hormonal contraception were low, the risk was increased by a factor of 0.9 to 1.7 with oral contraceptives that included ethinyl estradiol at a dose of 20 µg and by a factor of 1.3 to 2.3 with those that included ethinyl estradiol at a dose of 30 to 40 µg, with relatively small differences in risk according to progestin type.

S22591257

 

For novel therapeutic agents approved between 2001 and 2010, the FDA reviewed applications involving novel therapeutics more quickly, on average, than did the EMA or Health Canada, and the vast majority of these new therapeutic agents were first approved for use in the United States

 

BRITISH MEDICAL JOURNAL

 

S22674920

 

Booklet based vestibular rehabilitation for chronic dizziness is a simple and cost effective means of improving patient reported outcomes in primary care.

S22677795

 

Pre-diabetes, defined as impaired glucose tolerance or a combination of impaired fasting glucose and impaired glucose tolerance, may be associated with a higher future risk of stroke, but the relative risks are modest and may reflect underlying confounding.

S22539172

 

A single programme for people with newly diagnosed type 2 diabetes mellitus showed no difference in biomedical or lifestyle outcomes at three years although there were sustained improvements in some illness beliefs.

S22674921

 

The addition of a facilitated physical activity intervention to usual care did not improve depression outcome or reduce use of antidepressants compared with usual care alone.

S22653981

 

The use of pioglitazone is associated with an increased risk of incident bladder cancer among people with type 2 diabetes.

S22692650

 

Updated prediction models including age, sex, symptoms, and cardiovascular risk factors allow for accurate estimation of the pretest probability of coronary artery disease in low prevalence populations. Addition of coronary calcium scores to the prediction models improves the estimates.

S22619193

 

A single ultrasound guided dexamethasone injection is a safe and effective short term treatment for plantar fasciitis. It provides greater pain relief than placebo at four weeks and reduces abnormal  swelling of the plantar fascia for up to three months. However, clinicians offering this treatment  should also note that significant pain relief did not continue beyond four weeks.

S22674922

 

Combined with a low clinical probability of deep vein thrombosis, use of the age dependent D-dimer  cut-off value for patients older than 50 years or the cut-off value of 750 μg/L for patients aged  60 years and older resulted in a considerable increase in the proportion of patients in primary care in whom deep vein thrombosis could be safely excluded, compared with the conventional cut-off value  of 500 μg/L.

S22645184

 

Serum glucose levels on admission to hospital can predict death in patients with community acquired  pneumonia without pre-existing diabetes. Acute hyperglycaemia may therefore identify patients in need of intensified care to reduce the risk of death from community acquired pneumonia.

S22653982

 

The blood pressure and cholesterol lowering effects of dark chocolate consumption are beneficial in the prevention of cardiovascular events in a population with metabolic syndrome. Daily dark chocolate consumption could be an effective cardiovascular preventive strategy in this population.

 

                      

XXVIII Congreso de Comunicación y Salud

 

 

semFYC - JRT 2017

 

Cáceres, 10 y 11 de Noviembre 2017


____________________________

 Para pacientes
@pontealdiaAP
 @pontealdiaURG
55 e.SAMFyC

 


 

semFYC
 

 

Estadisticas

Ver contenido por hits : 1101559



La SAMFyC:
 C/ Arriola, 4, bajo D, CP.18001 - Granada. Email: samfyc@samfyc.es; Teléfono: 958 804 201 - Fax: 958 804 202. Horario de invierno: lunes a jueves de 9:00 a 17:30 horas; viernes de 9:00 a 14:30 horas. Horario de verano: lunes a viernes de 8:00 a 15:00h. Todos los derechos reservados. Aviso Legal. 


¡CSS Válido!

Diseño web